Table 5.
Na ≤135 mmol/l (n,%) | Na >135 mmol/l (n,%) | |||||
---|---|---|---|---|---|---|
Female n=39 |
Male N=49 |
p (test Chi2) |
Female n=175 |
Male N=201 |
p (test Chi2) |
|
NIHSS 0–12 | 32 (82.1%) | 30 (61.2%) | 0.0334 | 152 (86.9%) | 166 (82.6%) | 0.2529 |
NIHSS >12 | 7 (17.9%) | 19 (38.8%) | 23 (13.1%) | 35 (17.4%) | ||
mRankin 0–3 | 15 (38.5%) | 16 (32.7%) | 0.5710 | 126 (72%) | 115 (57.2%) | 0.0029 |
mRankin 4–6 | 24 (61.5%) | 33 (67.3%) | 49 (28%) | 86 (42.8%) | ||
1 month mortality | 2 (5.1%) | 10 (20.4%) | 0.0380 | 4 (2.3%) | 11 (5.5%) | 0.1153 |
NIHSS – National Institutes of Health Stroke Scale; mRankin – modified Rankin scale.